Autism

2
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

BrainsWay
BrainsWayJerusalem, Israel
1 program
1
Transcranial Magnetic StimulationPhase 21 trial
Active Trials
NCT01388179TerminatedEst. Dec 2016
ProgenaBiome
ProgenaBiomeCA - Ventura
1 program
1
Fecal Microbiota TransplantPhase 11 trial
Active Trials
NCT04630847Not Yet RecruitingEst. Jul 2027
Alliance Pharmaceuticals
2 programs
EEG Studies of Sensory Processing in Autistic ChildrenN/A1 trial
OxcarbazepineN/A1 trial
Active Trials
NCT00319722Unknown130Est. Mar 2011
NCT00467753Completed5Est. Dec 2011
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
The social ABCsN/A1 trial
Active Trials
NCT07025603Completed20Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
BrainsWayTranscranial Magnetic Stimulation
ProgenaBiomeFecal Microbiota Transplant
Jerusalem PharmaceuticalsThe social ABCs
Alliance PharmaceuticalsOxcarbazepine
Alliance PharmaceuticalsEEG Studies of Sensory Processing in Autistic Children

Clinical Trials (5)

Total enrollment: 155 patients across 5 trials

NCT01388179BrainsWayTranscranial Magnetic Stimulation

Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.

Start: Jan 2013Est. completion: Dec 2016
Phase 2Terminated
NCT04630847ProgenaBiomeFecal Microbiota Transplant

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Start: Dec 2025Est. completion: Jul 2027
Phase 1Not Yet Recruiting
NCT07025603Jerusalem PharmaceuticalsThe social ABCs

Evaluation of the Social ABCs in Israel

Start: Jun 2021Est. completion: Dec 202320 patients
N/ACompleted
NCT00467753Alliance PharmaceuticalsOxcarbazepine

Oxcarbazepine Versus Placebo in Childhood Autism

Start: Apr 2006Est. completion: Dec 20115 patients
N/ACompleted
NCT00319722Alliance PharmaceuticalsEEG Studies of Sensory Processing in Autistic Children

EEG Studies of Sensory Processing in Autistic Children

Start: Feb 2006Est. completion: Mar 2011130 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space